These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27368877)

  • 1. Slug Is Associated With Tumor Metastasis and Angiogenesis in Ovarian Cancer.
    Gu A; Jie Y; Yao Q; Zhang Y; Mingyan E
    Reprod Sci; 2017 Feb; 24(2):291-299. PubMed ID: 27368877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.
    Peng F; Zhong Y; Liu Y; Zhang Y; Xie Y; Lu Y; Zhang X; Li D
    Int J Oncol; 2017 Dec; 51(6):1920-1928. PubMed ID: 29075785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
    Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
    Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
    Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
    Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of X‑linked inhibitor of apoptosis‑associated factor‑1 in vasculogenic mimicry in ovarian cancer.
    Wang Y; Liu P; Wang X; Mao H
    Mol Med Rep; 2017 Jul; 16(1):325-330. PubMed ID: 28534973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level.
    Kurrey NK; K A; Bapat SA
    Gynecol Oncol; 2005 Apr; 97(1):155-65. PubMed ID: 15790452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VAV1 represses E-cadherin expression through the transactivation of Snail and Slug: a potential mechanism for aberrant epithelial to mesenchymal transition in human epithelial ovarian cancer.
    Wakahashi S; Sudo T; Oka N; Ueno S; Yamaguchi S; Fujiwara K; Ohbayashi C; Nishimura R
    Transl Res; 2013 Sep; 162(3):181-90. PubMed ID: 23856093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Betacellulin induces Slug-mediated down-regulation of E-cadherin and cell migration in ovarian cancer cells.
    Zhao J; Klausen C; Qiu X; Cheng JC; Chang HM; Leung PC
    Oncotarget; 2016 May; 7(20):28881-90. PubMed ID: 27129169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus.
    Ha JH; Ward JD; Radhakrishnan R; Jayaraman M; Song YS; Dhanasekaran DN
    Oncotarget; 2016 Jun; 7(25):37664-37679. PubMed ID: 27166196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SND1 acts upstream of SLUG to regulate the epithelial-mesenchymal transition (EMT) in SKOV3 cells.
    Xin L; Zhao R; Lei J; Song J; Yu L; Gao R; Ha C; Ren Y; Liu X; Liu Y; Yao Z; Yang J
    FASEB J; 2019 Mar; 33(3):3795-3806. PubMed ID: 30509125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer.
    Huang B; Yin M; Li X; Cao G; Qi J; Lou G; Sheng S; Kou J; Chen K; Yu B
    Oncotarget; 2016 May; 7(19):27552-66. PubMed ID: 27050277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis.
    Lu T; Wu B; Yu Y; Zhu W; Zhang S; Zhang Y; Guo J; Deng N
    Cancer Sci; 2018 Jul; 109(7):2221-2234. PubMed ID: 29737581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer.
    Wang Y; Mao H; Hao Q; Wang Y; Yang Y; Shen L; Huang S; Liu P
    Regul Pept; 2012 Oct; 178(1-3):36-42. PubMed ID: 22759793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis.
    Li Y; Xiao M; Guo F
    Tumour Biol; 2017 May; 39(5):1010428317705508. PubMed ID: 28475012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wip1 suppresses ovarian cancer metastasis through the ATM/AKT/Snail mediated signaling.
    Yin S; Wang P; Yang L; Liu Y; Wang Y; Liu M; Qi Z; Meng J; Shi TY; Yang G; Zang R
    Oncotarget; 2016 May; 7(20):29359-70. PubMed ID: 27121065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer.
    Wang X; Zhu Q; Lin Y; Wu L; Wu X; Wang K; He Q; Xu C; Wan X; Wang X
    Br J Cancer; 2017 Oct; 117(9):1371-1382. PubMed ID: 28898232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer.
    Chen Y; Zhang L; Liu WX; Wang K
    Cell Mol Biol Lett; 2018; 23():2. PubMed ID: 29308068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of CFTR expression is associated with tumor aggression and knockdown of CFTR suppresses proliferation of ovarian cancer in vitro and in vivo.
    Xu J; Yong M; Li J; Dong X; Yu T; Fu X; Hu L
    Oncol Rep; 2015 May; 33(5):2227-34. PubMed ID: 25738998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.